HNSN Hansen Medical, Inc. (MM)

Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in flexible medical robotics and the developer of robotic technology for accurate 3D control of catheter movement, announced today that it has appointed Peter Osborne, age 53, to serve as interim chief financial officer of the company effective February 24, 2010. Mr. Osborne, who will serve as the company's principal financial and accounting officer, replaces Steve Van Dick, who is resigning as an officer of Hansen Medical to pursue other opportunities. Hansen Medical has initiated a search for a permanent replacement for Mr. Van Dick.

Commenting on the resignation of Mr. Van Dick, Frederic Moll, M.D., president and chief executive officer of Hansen Medical, said, "I want to thank Steve for his effective leadership through a challenging and critical period for the company. As CFO, he made significant contributions, and we were extremely fortunate to have his service during the past four years. On behalf of Hansen Medical's employees and board of directors, we wish Steve all the best in his future endeavors."

Dr. Moll continued, "I am pleased to welcome Peter to Hansen Medical as interim chief financial officer. Peter brings nearly 30 years of accounting and financial acumen to our company, with extensive expertise as a senior level financial executive in the medical device industry. His previous experience makes him ideally suited to lead the company's finance and accounting teams during this transitional period."

Mr. Osborne has been an independent consultant providing senior level financial consulting services to companies since August 2009. Prior to becoming an independent consultant, Mr. Osborne served as chief financial officer, treasurer, and vice president of finance and administration of VNUS Medical Technologies, Inc., a medical device company, from January 2008 to July 2009 when the company was acquired. Mr. Osborne had previously been appointed as interim chief financial officer of VNUS in October 2007.

About Hansen Medical, Inc.

Hansen Medical Inc., based in Mountain View, Calif., develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. Its first product, the Sensei® Robotic Catheter system, is a robotic navigation system that enables clinicians to place mapping catheters in hard-to-reach anatomical locations within the heart easily, accurately and with stability during complex cardiac arrhythmia procedures. The Sensei system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data and was cleared by the U.S. Food and Drug Administration (FDA) in May 2007 for manipulation and control of certain mapping catheters in Electrophysiology (EP) procedures. The safety and effectiveness of the Sensei system for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation (AF), have not been established. In the European Union, the Sensei system is cleared for use during EP procedures, such as guiding catheters in the treatment of AF. Additional information can be found at www.hansenmedical.com.

News Media Contact: Amy Cook 925.552.7893 Email Contact Investor Contact: Lasse Glassen Financial Relations Board 213.486.6546 Email Contact